ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.641T>G (p.Leu214Arg)

dbSNP: rs137852911
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001580255 SCV001809899 likely pathogenic Glanzmann thrombasthenia 2024-08-20 reviewed by expert panel curation The ITGA2B missense variant NM_000419.5:c.641T>G replaces the leucine residue with an arginine residue (p.Leu214Arg). This variant has been observed in homozygosity in a proband (Patient B, PMID: 26096001; PM3_supporting) with a phenotype specific for Glanzmann's thrombasthenia (GT), including a history of bleeding and impaired aggregation to at least two agonists, but normal or only mildly reduced agglutination with ristocetin (PP4_Moderate). This variant has not been reported in population databases, including gnomADv4.1.0 (PM2_supporting) and is predicted to be damaging by in silico tools (REVEL score 0.797; PP3). Furthermore, a different missense change at this amino acid residue (ITGA2B c.641T>C (p.Leu214Pro)) is classified as pathogenic by the Platelet Disorders VCEP (PM5). In summary, this variant meets criteria to be classified as likely pathogenic for GT. GT-specific criteria applied: PM2_supporting, PM3_supporting, PM5, PP4_moderate, PP3.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.